Akèy › Atak kè › Tennessee › Memphis
Etid klinik pou Atak kè nan Memphis, TN
3 etid pou Atak kè ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Stern Cardiovascular Foundation Inc, Southaven · 11 mi lwen
- The Stern Cardiovascular Foundation, Germantown · 14 mi lwen
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Ap rekrite
- University of Tennessee Health Science Center/Regional One Health, Memphis
Etid Atak kè nan lòt vil
- New York City, NY6 etid
- Dallas, TX6 etid
- Rochester, MN6 etid
- Boston, MA5 etid
- Detroit, MI4 etid
- Boca Raton, FL4 etid
- Nashville, TN4 etid
- Knoxville, TN4 etid
- Los Angeles, CA4 etid
- Hartford, CT4 etid
- Houston, TX4 etid
- Greensboro, NC3 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete21 etid
- Maladi selil fòs18 etid
- Kansè poumon18 etid
- Leksemi limfoblastik egi16 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Kansè kolorektal11 etid
- Kansè pwostat11 etid
- Melanom11 etid
- Sarkom tisi mou11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.